Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio Key International (BKYI) Total Non-Current Liabilities (2016 - 2025)

Bio Key International's Total Non-Current Liabilities history spans 13 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities rose 178.36% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $1.1 million, up 178.36%, while the annual FY2024 figure was $289993.0, 20.79% up from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $1.1 million at Bio Key International, up from $132464.0 in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.1 million in Q3 2025 and bottomed at $132464.0 in Q2 2025.
  • The 5-year median for Total Non-Current Liabilities is $316586.0 (2024), against an average of $381587.9.
  • The largest annual shift saw Total Non-Current Liabilities soared 280.5% in 2022 before it tumbled 59.1% in 2023.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $154274.0 in 2021, then skyrocketed by 280.5% to $587011.0 in 2022, then crashed by 59.1% to $240081.0 in 2023, then increased by 20.79% to $289993.0 in 2024, then soared by 280.74% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for BKYI's Total Non-Current Liabilities are $1.1 million (Q3 2025), $132464.0 (Q2 2025), and $191007.0 (Q1 2025).